Literature DB >> 27483132

Infectious Complications after Major Abdominal Cancer Surgery: In Search of Improvable Risk Factors.

Linda C Smit1, Marjan J Bruins1, Gijs A Patijn2, Gijs J H M Ruijs1.   

Abstract

BACKGROUND: Major resections for esophageal, gastric, hepatic, pancreatic, and colorectal cancer continue to be associated with a high peri-operative morbidity of up to 30%-40%. To a large extent, this morbidity is caused by infectious complications that add up to a considerable burden to patients and hospital costs. The objective of this large retrospective cross-sectional study was to determine independent patient and operation-related risk factors for infectious complications after major abdominal cancer operations to elucidate how infection rates can be reduced and improve health-care quality. PATIENTS AND METHODS: In 1,389 cancer patients who underwent a major resection procedure between 2009 and 2013, infectious complications and their independent determinants were analyzed by multivariable logistic regression (p < 0.05).
RESULTS: Male gender was a risk factor for infections in general, whereas patients ≥65 y (odds ratio [OR] 1.75; p = 0.008), urinary tract infection (OR 0.51; p = 0.004), American Society of Anesthesiologists score (OR 1.55; p = 0.004), overall (OR 1.70; p = 0.037), vascular (OR 1.59; p = 0.020), and neurologic comorbidity (OR 2.22; p = 0.001) were associated significantly with pneumonia. Intra-abdominal drainage (OR 1.41; p = 0.024) and a duration of surgery of ≥180 min (OR 1.85; p = 0.001) were risk factors for surgical site infections. Total parenteral nutrition was significantly associated with intravascular catheter-induced infections (OR 18.09; p < 0.001) and sepsis (OR 6.69; p < 0.001).
CONCLUSIONS: In this study, several independent risk factors for infectious complications in major abdominal cancer operations were identified, providing opportunities for further reducing peri-operative infections. General awareness and focus on preventing infectious complications may have a significant impact on health-care outcomes and costs.

Entities:  

Mesh:

Year:  2016        PMID: 27483132     DOI: 10.1089/sur.2016.033

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  4 in total

1.  Respiratory Complications After Colorectal Surgery: Avoidable or Fate?

Authors:  Jonas Jurt; Martin Hübner; Basile Pache; Dieter Hahnloser; Nicolas Demartines; Fabian Grass
Journal:  World J Surg       Date:  2018-09       Impact factor: 3.352

2.  Statin therapy and postoperative short-term mortality after rectal cancer surgery.

Authors:  Arvid Pourlotfi; Rebecka Ahl; Gabriel Sjolin; Maximilian Peter Forssten; Gary A Bass; Yang Cao; Peter Matthiessen; Shahin Mohseni
Journal:  Colorectal Dis       Date:  2020-12-23       Impact factor: 3.788

Review 3.  Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper.

Authors:  Tim Cooksley; Carme Font; Florian Scotte; Carmen Escalante; Leslie Johnson; Ronald Anderson; Bernardo Rapoport
Journal:  Support Care Cancer       Date:  2020-11-23       Impact factor: 3.603

4.  Cefoxitin versus piperacillin-tazobactam as surgical antibiotic prophylaxis in patients undergoing pancreatoduodenectomy: protocol for a randomised controlled trial.

Authors:  Nicole M Nevarez; Brian C Brajcich; Jason Liu; Ryan Ellis; Clifford Y Ko; Henry A Pitt; Michael I D'Angelica; Adam C Yopp
Journal:  BMJ Open       Date:  2021-03-04       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.